Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-centre, Observational, Post-market, Real World Registry to Assess Outcomes of Patients Treated With the Gore® EXCLUDER® ILIAC BRANCH Endoprosthesis

NCT02345005 is registered in ClinicalTrials.gov with Rijnstate Hospital as lead sponsor.

NCT NCT02345005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02345005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-centre, Observational, Post-market, Real World Registry to Assess Outcomes of Patients Treated With the Gore® EXCLUDER® ILIAC BRANCH Endoprosthesis
Lead sponsor
Rijnstate Hospital
Phase
Observational
Overall status
Completed
Start date
November 30, 2014
Completion date
July 31, 2025
Enrollment
100 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysms, aneurysm, common iliac aneurysms